Reviva Pharmaceuticals is based in Cupertino, CA. It has raised $138M in total funding. Latest round: IPO.
Reviva Pharmaceuticals funding overview
Reviva Pharmaceuticals is based in Cupertino, CA. Reviva Pharmaceuticals has raised $138M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in December 2020. The round record for Reviva Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include 200 individual investors (including medical doctors).
Reviva Pharmaceuticals at a glance
Total raised
$138M
Latest round
IPO
Latest round date
December 2020
Headquarters
Cupertino, CA
Notable investors
200 individual investors (including medical doctors)
Frequently asked about Reviva Pharmaceuticals funding
How much has Reviva Pharmaceuticals raised?
Reviva Pharmaceuticals has raised $138M in total disclosed funding across the rounds on record.
Who has invested in Reviva Pharmaceuticals?
200 individual investors (including medical doctors) are named among the investors backing Reviva Pharmaceuticals.
What was the latest Reviva Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in December 2020.
Where is Reviva Pharmaceuticals based?
Reviva Pharmaceuticals is based in Cupertino, CA.
When did Reviva Pharmaceuticals last raise?
The last disclosed Reviva Pharmaceuticals round closed in December 2020 at IPO.
We update the Reviva Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cupertino and their backers are listed below.
